ArticleCancers2022

A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes.

Esteban Astiazaran-Symonds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.